Brii Biosciences Ltd
HKEX:2137
Brii Biosciences Ltd
HKEX:2137
Price:
1.34 HKD
5.51%
Market Closed
Updated:
May 19, 2024
Brii Biosciences Ltd
Cash from Financing Activities
|
Brii Biosciences Ltd
Cash from Financing Activities Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Brii Biosciences Ltd
HKEX:2137
|
Cash from Financing Activities
-¥11m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Cash from Financing Activities
¥2.6B
|
CAGR 3-Years
-57%
|
CAGR 5-Years
-25%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Cash from Financing Activities
¥2.6B
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Cash from Financing Activities
-¥893.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Cash from Financing Activities
-¥4.6B
|
CAGR 3-Years
-27%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-50%
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Cash from Financing Activities
-¥374.2m
|
CAGR 3-Years
-104%
|
CAGR 5-Years
-98%
|
CAGR 10-Years
N/A
|
See Also
What is Brii Biosciences Ltd's Cash from Financing Activities?
Cash from Financing Activities
-11m
CNY
-11m
CNY
Based on the financial report for Dec 31, 2023, Brii Biosciences Ltd's Cash from Financing Activities amounts to -11m CNY.
What is Brii Biosciences Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 1Y
-261%
-261%
Over the last year, the Cash from Financing Activities growth was -261%.
You don't have any saved screeners yet
